Page 7 - GHES-2-1
P. 7
MINI-REVIEW
14 A descriptive model featuring expansive clinical microbiology approaches and antimicrobial
stewardship to control antimicrobial resistance in low- and middle-income countries
Emmanuel Oladayo Irek, Olukemi Titilope Olugbade, Anthony Chinemere Anuforo
LETTER TO EDITOR
15 Budgetary impact of new label indications after initial drug registration in Brazil: A case
study of pembrolizumab and trastuzumab deruxtecan
Bruno Salgado Riveros, Marina Gatto Cavalcanti, Letícia Paula Leonart, Mariana Papaléo Rosim, André Bergamim Almeida,
Cristiane Aparecida Licursi
v
